Quell private stock trade

Quell

Legal NameQuellTX Ltd.
HeadquartersLondon, England
SectorBioTech

Developer of T regulatory (Treg) cells designed to treat diseases of the immune system. The company's products are transformational and valued therapies for a range of autoimmune and inflammatory diseases as well as preventing rejection in organ transplantation based on modular engineered Tregs, enabling clients to get transplant rejection and autoimmune and inflammatory care.

Learn more about Quell IPO

Secondary Pricing Information

$ .star in blue circleZX Index Value | Get ZXData access
--ZX Index Value MoM Change
--ZX Index Value VS Reported Marks
pricing graph placeholder
star in blue circleTo view Pre-IPO pricing data for Quell, log in to ZXData or contact us to request access.
<

Secondary Volume Information

$ .M star in blue circleAggregate Volume | Get ZXData access
volume graph placeholder
star in blue circleTo view Pre-IPO volume data for Quell, log in to ZXData or contact us to request access.
View More

ZXData is the leading provider of real-time secondary data on private companies. ZXData has the largest dataset of closed trades with $15bn+ in volume. In addition, it incorporates $150bn+ of buy/sell prices and $45bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.